Abstract

Aims and MethodsThe study compared two methods of identifying patients prescribed high doses of antipsychotic medication among in-patients and out-patients in Buckinghamshire. High doses were defined as those in excess of 1000 mg chlorpromazine equivalents (CPZE) per day or more than 100% of the maximum recommended dose in the British National Formulary (BNF).ResultsA total of 258 patients were identified as being prescribed antipsychotics, 30 of whom received high doses. There was 93% concordance between the two methods for identifying these patients. Nine of the 12 patients who had been prescribed high potency (> 1000 mg CPZE/day) but low toxicity (> 100% BNF maximum) therapy were receiving flupenthixol decanoate.A group of six high-risk patients were identified who had been prescribed lower potency drugs at supra-maximal doses.Clinical ImplicationsExpressing total antipsychotic dose as a percentage of the BNF maximum is easy to understand and calculate. It helps to ensure patients at risk of antipsychotic toxicity are easily identified to ensure monitoring guidelines can be followed.

Highlights

  • A total of 258 patients were identified as being prescribed antipsychotics, 30 of whom received high doses

  • The antipsychotic dose was calculated in chlorpromazine equivalents (CPZE) using the conversion table in Bazire (1995), and as a percentage of the British National Formulary (BNF) maximum recommended dose

  • High doses were defined as more than 100% of the BNF maximum or more than 100 mg CPZE /day

Read more

Summary

AIMS AND METHOD

High doses were defined as those in excess of 1000 mg chlorpromazine equivalents (CPZE) per day or more than 100% of the maximum recommended dose in the British National Formulary (BNF)

RESULTS
CLINICAL IMPLICATIONS
The study
Findings
Group C
Oral One antipsychotic Two antipsychotics ö ö ö
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.